SCD and liver cancer: In many cancers such as breast, colorectal, pancreatic, and liver cancer, the saturated/monounsaturated fatty acid (SFA/MUFA) ratio is commonly dysregulated [52], suggesting that increased SCD1 activity might be a biochemical hallmark of tumorigenesis that prevent SFA accumulation and promote growth.